Literature DB >> 10323245

Repositioning the hereditary paraganglioma critical region on chromosome band 11q23.

B E Baysal1, E M van Schothorst, J E Farr, P Grashof, D Myssiorek, W S Rubinstein, P Taschner, C J Cornelisse, B Devlin, P Devilee, C W Richard.   

Abstract

Hereditary paragangliomas (PGL, glomus tumors, MIM no.168000) are mostly benign, slow-growing tumors of the head and neck region. The gene (or genes) affecting risk to PGL are subject to genomic imprinting: children of affected fathers exhibit an autosomal dominant pattern of disease inheritance, whereas children of affected mothers rarely if ever develop the disease through maternal transmission. We previously confined the disease gene to an approximately 6 Mb critical region on chromosome band 11q23 (PGL1). Based on haplotype analysis of an extended Dutch pedigree, a 2 Mb sub-region between D11S938 and D11S1885 was proposed as the PGL1 critical interval. In this study, we excluded this interval by analysis of two new single tandem repeat polymorphisms (STRP) contained therein. Instead, we predicted a non-overlapping, more proximal 2 Mb critical interval between D11S1647 and D11S897, and evaluated this new region using nine STRP (D11S1986, five new, closely-linked STRP, D11S1347, D11S3178, and D11S1987). Consistent with our prediction, we observed substantial haplotype-sharing within the Dutch pedigree. We also analyzed four new American PGL families. A recombination event detected in one family further defined D11S1347 as the new telomeric border. We observed significant haplotype-sharing within this new interval among three unrelated American PGL families, strongly suggesting that they originated from a common ancestor. Thus, we confined PGL1 to an approximately 1.5 Mb region between D11S1986 and D11S1347, and showed identity-by-descent sharing for a group of American PGL families.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10323245     DOI: 10.1007/s004390050939

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  8 in total

1.  Haplotype fine mapping by evolutionary trees.

Authors:  J C Lam; K Roeder; B Devlin
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 2.  SDHC mutations in hereditary paraganglioma/pheochromocytoma.

Authors:  Ulrich Müller; Christian Troidl; Stephan Niemann
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

3.  Differential loss of chromosome 11q in familial and sporadic parasympathetic paragangliomas detected by comparative genomic hybridization.

Authors:  H Dannenberg; R R de Krijger; J Zhao; E J Speel; P Saremaslani; W N Dinjens; W J Mooi; J Roth; P U Heitz; P Komminoth
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

4.  Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.

Authors:  B E Baysal; J E Willett-Brozick; E C Lawrence; C M Drovdlic; S A Savul; D R McLeod; H A Yee; D E Brackmann; W H Slattery; E N Myers; R E Ferrell; W S Rubinstein
Journal:  J Med Genet       Date:  2002-03       Impact factor: 6.318

Review 5.  Hereditary paraganglioma targets diverse paraganglia.

Authors:  B E Baysal
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

6.  Sinonasal paraganglioma: a case report.

Authors:  Ayotunde J Fasunla; Titus S Ibekwe; Olushola A Afolabi; Paul A Onakoya; Olayiwola A Oluwasola; Olabiyi G Ogun; Adewunmi O Adeoye; Onyekwere G Nwaorgu
Journal:  Oral Maxillofac Surg       Date:  2008-07

7.  Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect.

Authors:  Kristin Astrom; Joel E Cohen; Joan E Willett-Brozick; Christopher E Aston; Bora E Baysal
Journal:  Hum Genet       Date:  2003-06-17       Impact factor: 4.132

8.  Common variations in ALG9 are not associated with bipolar I disorder: a family-based study.

Authors:  Bora E Baysal; Joan E Willett-Brozick; Silviu-Alin Bacanu; Sevilla Detera-Wadleigh; Vishwajit L Nimgaonkar
Journal:  Behav Brain Funct       Date:  2006-07-21       Impact factor: 3.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.